BMPR1A
Spezies: Human
Wirt: HEK-293 Cells
Recombinant
The purity of the protein is greater than 95 % as determined by SDS-PAGE and Coomassie blue staining.
BMPR1A
Spezies: Hund
Wirt: HEK-293 Cells
Recombinant
> 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Reconstitute first in sterile distilled water, and further dilute into PBS or medium containing at least 0.1 % human or BSA to a concentration not lower than 100 µg/mL
Buffer
Supplied as a lyophilized powder.
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C/-80 °C
Informationen zur Lagerung
Store at -70 °C until reconstitution. Following reconstitution product should be aliquoted and frozen at -20 °C.
Target
BMPR1A
(Bone Morphogenetic Protein Receptor 1A (BMPR1A))
Cellular responses to bone morphogenetic proteins (BMPs) have been shown to be mediated by the formation of hetero-oligomeric complexes of the type I and type II serine/threonine kinase receptors. BMP receptor 1A (BMPR-1A), also known as activin receptor-like kinase (ALK)-3, is a one of seven known type I serine/threonine kinases that are required for the signal transduction of TGF-b family cytokines. Alternative Names: Bone Morphogenetic Protein Receptor 1A protein, BMPR-1A protein, BMPRA-1, BMPRA 1, BMPR1A, BMPRA-1 protein, BMPRA 1 protein